C

Curaleaf Holdings Inc
CNSX:CURA

Watchlist Manager
Curaleaf Holdings Inc
CNSX:CURA
Watchlist
Price: 6.59 CAD 0.15% Market Closed
Market Cap: 4.8B CAD
Have any thoughts about
Curaleaf Holdings Inc?
Write Note

Intrinsic Value

The intrinsic value of one CURA stock under the Base Case scenario is 3.51 CAD. Compared to the current market price of 6.59 CAD, Curaleaf Holdings Inc is Overvalued by 47%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CURA Intrinsic Value
3.51 CAD
Overvaluation 47%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation Backtest
Curaleaf Holdings Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CURA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CURA?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Curaleaf Holdings Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Curaleaf Holdings Inc

Provide an overview of the primary business activities
of Curaleaf Holdings Inc.

What unique competitive advantages
does Curaleaf Holdings Inc hold over its rivals?

What risks and challenges
does Curaleaf Holdings Inc face in the near future?

Summarize the latest earnings call
of Curaleaf Holdings Inc.

What significant events have occurred
in Curaleaf Holdings Inc over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Curaleaf Holdings Inc.

Provide P/S
for Curaleaf Holdings Inc.

Provide P/E
for Curaleaf Holdings Inc.

Provide P/OCF
for Curaleaf Holdings Inc.

Provide P/FCFE
for Curaleaf Holdings Inc.

Provide P/B
for Curaleaf Holdings Inc.

Provide EV/S
for Curaleaf Holdings Inc.

Provide EV/GP
for Curaleaf Holdings Inc.

Provide EV/EBITDA
for Curaleaf Holdings Inc.

Provide EV/EBIT
for Curaleaf Holdings Inc.

Provide EV/OCF
for Curaleaf Holdings Inc.

Provide EV/FCFF
for Curaleaf Holdings Inc.

Provide EV/IC
for Curaleaf Holdings Inc.

Show me price targets
for Curaleaf Holdings Inc made by professional analysts.

What are the Revenue projections
for Curaleaf Holdings Inc?

How accurate were the past Revenue estimates
for Curaleaf Holdings Inc?

What are the Net Income projections
for Curaleaf Holdings Inc?

How accurate were the past Net Income estimates
for Curaleaf Holdings Inc?

What are the EPS projections
for Curaleaf Holdings Inc?

How accurate were the past EPS estimates
for Curaleaf Holdings Inc?

What are the EBIT projections
for Curaleaf Holdings Inc?

How accurate were the past EBIT estimates
for Curaleaf Holdings Inc?

Compare the revenue forecasts
for Curaleaf Holdings Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Curaleaf Holdings Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Curaleaf Holdings Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Curaleaf Holdings Inc compared to its peers.

Compare the P/E ratios
of Curaleaf Holdings Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Curaleaf Holdings Inc with its peers.

Analyze the financial leverage
of Curaleaf Holdings Inc compared to its main competitors.

Show all profitability ratios
for Curaleaf Holdings Inc.

Provide ROE
for Curaleaf Holdings Inc.

Provide ROA
for Curaleaf Holdings Inc.

Provide ROIC
for Curaleaf Holdings Inc.

Provide ROCE
for Curaleaf Holdings Inc.

Provide Gross Margin
for Curaleaf Holdings Inc.

Provide Operating Margin
for Curaleaf Holdings Inc.

Provide Net Margin
for Curaleaf Holdings Inc.

Provide FCF Margin
for Curaleaf Holdings Inc.

Show all solvency ratios
for Curaleaf Holdings Inc.

Provide D/E Ratio
for Curaleaf Holdings Inc.

Provide D/A Ratio
for Curaleaf Holdings Inc.

Provide Interest Coverage Ratio
for Curaleaf Holdings Inc.

Provide Altman Z-Score Ratio
for Curaleaf Holdings Inc.

Provide Quick Ratio
for Curaleaf Holdings Inc.

Provide Current Ratio
for Curaleaf Holdings Inc.

Provide Cash Ratio
for Curaleaf Holdings Inc.

What is the historical Revenue growth
over the last 5 years for Curaleaf Holdings Inc?

What is the historical Net Income growth
over the last 5 years for Curaleaf Holdings Inc?

What is the current Free Cash Flow
of Curaleaf Holdings Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Curaleaf Holdings Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Curaleaf Holdings Inc

Current Assets 483.8m
Cash & Short-Term Investments 118.1m
Receivables 43.8m
Other Current Assets 321.9m
Non-Current Assets 2.7B
Long-Term Investments 2.5m
PP&E 836m
Intangibles 1.9B
Other Non-Current Assets 48m
Current Liabilities 556.2m
Accounts Payable 63.7m
Accrued Liabilities 118m
Other Current Liabilities 374.5m
Non-Current Liabilities 1.6B
Long-Term Debt 884.9m
Other Non-Current Liabilities 692.7m
Efficiency

Earnings Waterfall
Curaleaf Holdings Inc

Revenue
2.3B USD
Cost of Revenue
-1.3B USD
Gross Profit
1B USD
Operating Expenses
-1B USD
Operating Income
12.2m USD
Other Expenses
-600.3m USD
Net Income
-588.1m USD

Free Cash Flow Analysis
Curaleaf Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Curaleaf Holdings reported a modest 4% increase in Q2 2023 revenue, hitting $339 million. Adjusted gross margin dropped to 44%, due to strategic inventory reduction and pricing pressures, notably in Florida and New York. The company also generated $8 million in free cash flow after significant payments. Aggressive measures to control costs, such as reducing expenses by $80 million and inventory by $17 million, have been implemented to adapt to a normalizing growth environment. Internationally, the UK and Germany key markets contributed to a 93% surge in international revenue, despite dragging EBITDA margins down by 150 basis points. With new German legislation anticipated to commence in early 2024, Curaleaf is well-positioned to capitalize on European market expansions, setting the potential for the company as a significant long-term global growth platform.

What is Earnings Call?
Fundamental Scores

CURA Profitability Score
Profitability Due Diligence

Curaleaf Holdings Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Exceptional 1-Year Revenue Growth
Positive 3-Year Average ROIC
Positive Gross Profit
36/100
Profitability
Score

Curaleaf Holdings Inc's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

CURA Solvency Score
Solvency Due Diligence

Curaleaf Holdings Inc's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
31/100
Solvency
Score

Curaleaf Holdings Inc's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CURA Price Targets Summary
Curaleaf Holdings Inc

There are no price targets for CURA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CURA?

Click here to dive deeper.

Dividends

Curaleaf Holdings Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CURA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

CURA News

Other Videos

Profile

Curaleaf Holdings Inc

Country

Canada

Industry

Pharmaceuticals

Market Cap

4.8B CAD

Dividend Yield

0%

Description

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. The company is headquartered in Vancouver, British Columbia and currently employs 5,138 full-time employees. The company went IPO on 2015-10-22. The firm improves lives by providing cannabis for consumption. The firm and its brands, including Curaleaf and Select, provide service, product selection and accessibility across the medical and adult-use markets. The firm operates in 23 states with 123 dispensaries and 25 cultivation sites. The company focuses on populated, limited license states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York, and Pennsylvania. Curaleaf International is the vertically integrated cannabis company in Europe with a supply and distribution network throughout the European market, bringing together science and research with cultivation, extraction and production. The firm's brands also include Curaleaf Hemp and UKU Cannabis. Curaleaf is a national retail dispensary brand in the United States, which is available in multiple states and product formats.

Contact

BRITISH COLUMBIA
Vancouver
666 Burrard Street, Suite 1700
+16042184766.0
ir.curaleaf.com

IPO

2015-10-22

Employees

5 138

Officers

Exec. Chairman
Mr. Boris Alexis Jordan
Exec. Vice-Chairman
Mr. Joseph F. Lusardi
Exec. Officer & Exec. of New Markets
Mr. Joseph Daniel Bayern
Chief Exec. Officer
Mr. Matthew S. Darin
Chief Financial Officer
Mr. Edward Kremer
Exec. VP of Operations
Mr. Joe Holland
Show More
Chief Investment Officer
Mr. Camilo Russi Lyon
Mang. of Investor Relations
Mr. Jakob Feinstein
Chief Legal Officer
Mr. Peter Clateman J.D.
Chief Compliance Officer
Mr. James S. Shorris
Show Less

See Also

Discover More
What is the Intrinsic Value of one CURA stock?

The intrinsic value of one CURA stock under the Base Case scenario is 3.51 CAD.

Is CURA stock undervalued or overvalued?

Compared to the current market price of 6.59 CAD, Curaleaf Holdings Inc is Overvalued by 47%.

Back to Top